TuHURA Biosciences, Inc.
HURA
$2.01
-$0.11-5.19%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -9.22M | -7.54M | -6.76M | -7.10M | -9.52M |
| Total Depreciation and Amortization | 28.10K | 23.50K | 22.50K | 21.30K | 13.40K |
| Total Amortization of Deferred Charges | 295.30K | -- | 481.40K | -- | -- |
| Total Other Non-Cash Items | 2.14M | 2.80M | 240.90K | 1.95M | 1.41M |
| Change in Net Operating Assets | -1.88M | 303.90K | 460.50K | -5.95M | 1.86M |
| Cash from Operations | -8.63M | -4.41M | -5.56M | -11.09M | -6.25M |
| Capital Expenditure | -137.00K | -48.80K | -27.90K | 0.00 | -5.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 0.00 | 0.00 | -150.90K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -137.00K | -48.80K | -27.90K | 0.00 | -156.50K |
| Total Debt Issued | 3.60M | -- | 3.00M | -- | -- |
| Total Debt Repaid | -11.10K | -208.20K | -1.81M | -576.30K | -- |
| Issuance of Common Stock | 311.00K | 7.50M | 6.19M | 6.20M | 9.03M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -2.10K | -2.10K | -2.10K | -2.10K | -2.10K |
| Other Financing Activities | -429.50K | -149.70K | -876.00K | -348.00K | -331.40K |
| Cash from Financing | 3.47M | 7.14M | 6.51M | 5.27M | 8.70M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.30M | 2.68M | 922.50K | -5.82M | 2.29M |